Hestia Insight is a small, three-person advisory and consulting firm that helps early-stage and growth-stage companies raise capital. Hestia Insight positions itself as "AI-powered" and covers the fundraising process end-to-end, including pre-raise strategy, MVP development guidance, IP protection, market research, financial modeling, pitch decks, due diligence support, and investor relations management. The firm also offers fractional C-suite services, giving clients part-time Chief Strategy Officer and CFO support. Hestia Insight's stated focus is on healthcare and biotech, though it serves clients across industries. Its customers are startups, small businesses, and small and micro-cap public companies with limited access to growth capital, and the firm generates new business primarily through senior management's personal networks. Hestia Insight operates through two wholly owned subsidiaries, Hestia Investments and HSTA Health, and also pursues acquisitions, licensing arrangements, joint ventures, and direct investments in healthcare and biotech companies, though the scale of this activity is unclear given the firm's size. Revenue is driven by the number of client engagements and the scope of services per client, ranging from discrete project work to ongoing advisory relationships.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →